Serenitas Infra Private Limited - Company overview

Southern Pharma India was incorporated on 22 April 2015 and is registered with ROC Vijayawada.

2015-04-22 Visakhapatnam, Andhra Pradesh Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹1–5 Cr
▲ 580.0%
FY 2020
PROFIT / LOSS
Loss · ₹5–10 Cr
▼ -369.7%
FY 2020
EBITDA
Loss · ₹1–5 Cr
▼ -623.4%
FY 2020
NET WORTH
Loss · ₹1–5 Cr
▼ -125.9%
FY 2020
TOTAL ASSETS
₹10–25 Cr
▼ -18.4%
FY 2020
OPEN CHARGES
1
-
PAID-UP CAPITAL
9.12 cr
AUTHORISED CAPITAL
12.00 cr
COMPANY AGE
11 Years 6 Months
since 2015-04-22
LAST FILING WITH ROC
2022-03-31
Last AGM: 2022-10-10
ACTIVE GST
1
Updated: 2023-02-27 08:47:14
TOTAL MONEY RAISED
₹10–25 Cr
SATISFIED CHARGES
1
10.80 cr

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Southern Pharma India covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Moderate
63/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (68), financial health (20), director (95) and company-foundation signals.
  • Operating for 11+ years.
Compliance Score Moderate
68/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2022 - filings look overdue.
Financial Health Score High risk
20/100
Profitability, leverage and liquidity from filed statements.
  • Loss-making in FY 2020.
  • Negative net worth - capital eroded by losses.
Director Risk Score Low risk
95/100
Board strength, DIN status and churn.
  • 3 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Southern Pharma India Company identity, industry, contact, and registration details from MCA and company records.

Southern Pharma India was incorporated on 22 April 2015 and is registered with ROC Vijayawada. It is an active private limited company, now about 11 years old. Its registered office is in Visakhapatnam, Andhra Pradesh.

Its filings describe the main line of business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, which made up 100% of turnover.

It has three directors: Nirmala Earla, Earla Padma and Sreedhar Bodakunta. Nine former directors are on record; the most recent to leave was Rakesh Kolli in November 2022. Between them, the directors also sit on the boards of 2 other companies, including Shilada LLP and Vijetha Infraprojects Private Limited.

Paid-up capital stands at ₹9.12 crore out of ₹12 crore authorised. The last AGM on record was on 10 October 2022, for accounts made up to 31 March 2022. Nothing newer than 2022 shows up here, so it is worth checking the MCA portal for later filings. The one charge registered against it has been satisfied, so no secured loan is open.

Pharma ••••••••
  • Location Flat No.5,3Rd Floor,D-Block,Shakunthala Apartment Ocean View Layout, Siripuram,, Visakhapatnam, Andhra Pradesh - 530017
  • Website spipl.in
Legal NameSerenitas Infra Private Limited
CIN / LLPINU24100AP2015PTC096540
Company No.096540
ClassificationPrivate Limited Indian Non-Government Company
Incorporation Date2015-04-22
Date of AGM2022-10-10
Date of Balance Sheet2022-03-31
Listing StatusUnlisted
ROC CodeRoc Vijayawada
Credit RatingD (Care)
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Southern Pharma India (3) Current board members from MCA filings, including designation and appointment details.

N
Nirmala Earla
Director | Since 2018-06-26 | DIN: 08165949
E
Earla Padma
Director | Since 2018-06-26 | DIN: 08165973
S
Sreedhar Bodakunta
Director | Since 2018-07-02 | DIN: 00550647

Financial Performance of Southern Pharma India Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2020
Revenue ₹1–5 Cr ▲ 580.0%
P&L Loss · ₹5–10 Cr ▼ -369.7%
EBITDA Loss · ₹1–5 Cr ▼ -623.4%
Net worth Loss · ₹1–5 Cr ▼ -125.9%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of Southern Pharma India Open and satisfied charges registered against the company with MCA.

Vijaya Bank : 10.80 cr
Open Charges: 1 Satisfied Charges: 1
Open -
Satisfied 10.80 cr
LenderAmountStatus
Vijaya Bank
Creation Date: 02 Nov 2016
 10.80 cr Closed

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
ManufacturingChemical and chemical products, pharmaceuticals, medicinal chemical and botanical products100

Companies With Common Directors Of Southern Pharma India Other companies that share directors with this entity, based on MCA and compliance network data.

Board Overlap From MCA / Compliance Filings

Shilada Llp 2 Shared Directors
Vijetha Infraprojects Private Limited 1 Shared Director

Financial Ratios of Southern Pharma India Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

5 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Southern Pharma India Ownership and contribution detail from filings. Full breakdown unlocks with your report.

2 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at Southern Pharma India EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of Southern Pharma India GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Southern Pharma India Ratings, court records, and regulatory alerts. Full risk detail unlocks with your report.

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

Rating history Court and tribunal cases Regulatory alerts Director-linked violations

Credit ratings, litigation, and regulatory alerts require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Southern Pharma India MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Southern Pharma India Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Southern Pharma India Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Southern Pharma India?
MCA does not publish an "owner" field. Southern Pharma India is run by its directors, Nirmala Earla, Earla Padma and Sreedhar Bodakunta. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Southern Pharma India?
Southern Pharma India has three current directors: Nirmala Earla (since June 2018), Earla Padma (since June 2018) and Sreedhar Bodakunta (since July 2018).
What is CIN of Southern Pharma India?
The CIN of Southern Pharma India is U24100AP2015PTC096540. Reading it left to right: U means it is not listed, 24100 is the industry code it registered under, AP is Andhra Pradesh, 2015 is the year it was registered, PTC is the company type and 096540 is its registration number.
When was Southern Pharma India incorporated?
Southern Pharma India was incorporated on 22 April 2015 with ROC Vijayawada. That makes it about 11 years old.
What is the registered address of Southern Pharma India?
The registered office on MCA records is Flat No.5, 3Rd Floor, D-Block, Shakunthala Apartment Ocean View Layout, Siripuram, Visakhapatnam, Andhra Pradesh - 530017.
What is the current status of Southern Pharma India?
MCA shows Southern Pharma India as Active, and its last AGM on record was in October 2022.
What is the contact number or email for Southern Pharma India?
You can post to its registered office at Flat No.5, 3Rd Floor, D-Block, Shakunthala Apartment Ocean View Layout, Siripuram, Visakhapatnam, Andhra Pradesh - 530017 and use its website, https://spipl.in.
What industry or business activity is Southern Pharma India associated with?
Its MCA filings list the main business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products (100% of turnover).
What is paid-up capital and authorised share capital of Southern Pharma India?
Paid-up capital is ₹9.12 crore and authorised capital is ₹12 crore, so about 76% of the authorised amount has been issued.
When did Southern Pharma India last file accounts and hold an AGM?
The last AGM on record was on 10 October 2022, and the latest balance sheet is for the year ending 31 March 2022. Nothing newer than 2022 shows up, so check the MCA portal for later filings.
Where can I see charges and lenders for Southern Pharma India?
No charge is open. The one charge registered against Southern Pharma India has been satisfied. Lenders named in the filings include Vijaya Bank.
Have any directors left Southern Pharma India?
Yes, nine former directors are on record. The most recent to leave were Rakesh Kolli (November 2022), Pilli Venkata Jagathula Sarveswaraiah (May 2022) and Kalpeshkumar Pravinchandra Bhatt (December 2021).
Which companies share directors with Southern Pharma India?
2 companies share directors with Southern Pharma India: Shilada LLP and Vijetha Infraprojects Private Limited.
What is the turnover or revenue of Southern Pharma India?
Based on filed financial statements, the revenue of Southern Pharma India for FY 2020 was in the ₹1–5 Cr range. That is up 580.0% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Southern Pharma India?
For FY 2020, the net worth of Southern Pharma India was negative, in the ₹1–5 Cr range.
How can I get the financial details of Southern Pharma India?
The latest accounts on record are for FY 2020. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Southern Pharma India?
The website on record for Southern Pharma India is https://spipl.in.
Which company owns spipl.in?
spipl.in is the website listed for Serenitas Infra Private Limited in its company records.
Southern Pharma India - is it listed or unlisted?
Southern Pharma India is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Southern Pharma India?
Southern Pharma India is registered with ROC Vijayawada.
What is the company classification of Southern Pharma India?
MCA classifies Southern Pharma India as: Private Limited Indian Non-Government Company.
Does Southern Pharma India have GST registrations on file?
Yes, one active GST registration is linked to Southern Pharma India.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.